BioValeo Ltd
BioValeo Ltd is a bespoke trans-Tasman contract research organisation specialising in advanced therapy medicinal product and complex clinical trial execution across Australia and New Zealand, serving pharmaceutical and biotech sponsors from offices in Wellington and Auckland.
- Company typePrivate
- Founded-
- HeadquartersWellington, New Zealand
- Headcount1–10
- GTM typeB2B
- OfferingServices
What BioValeo Ltd does
BioValeo Ltd is a bespoke contract research organisation (CRO) that provides clinical trial support services to sponsors of advanced therapy medicinal products (ATMPs) and other complex clinical research. The company operates across Australia and New Zealand, with headquarters in Wellington and an additional office in Auckland. Its service portfolio covers the full operational lifecycle of a regional clinical study, including study country planning, regulatory submissions, project management, data management (via electronic data capture and case report form systems), and on-site monitoring services.
The company targets pharmaceutical and biotechnology sponsors running ATMP and complex trial programmes that require localised regulatory and operational expertise in the trans-Tasman market. Its technical stack is centred on conventional EDC and CRF data management infrastructure rather than proprietary platforms, and its differentiation rests on specialist know-how in cell and gene therapy trial execution rather than technology ownership.
BioValeo is privately held and operates with a six-person team. It is backed by Bridgewest Ventures NZ LP, part of the Bridgewest Group, and is a participant in Callaghan Innovation's Technology Incubator Programme. Revenue is generated through project-based contracts with sponsors; the company acquires customers via direct outreach through its website and email contact channels rather than through established channel partnerships or referral networks.
BioValeo Ltd firmographics
Firmographics- Name
- BioValeo Ltd
- Legal name
- BioValeo Ltd.
- Website
- https://biovaleo.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BioValeo Ltd is a bespoke trans-Tasman contract research organisation specialising in advanced therapy medicinal product and complex clinical trial execution across Australia and New Zealand, serving pharmaceutical and biotech sponsors from offices in Wellington and Auckland.
- Ownership category
- akta.pro rank
BioValeo Ltd industry classification
Industry- Product category
- Contract Research Organization (CRO) Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industry
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
Keywords
Where BioValeo Ltd is headquartered
LocationHeadquarters
- HQ city
- Wellington
- HQ country
- New Zealand
- HQ region
- Oceania
Offices2 records
Markets served
BioValeo Ltd business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- CRO Professional Services: BioValeo generates revenue through providing bespoke Contract Research Organisation services for clinical trials, including study country planning, regulatory submissions, project management, data management, and monitoring services. Services are tailored to each client and study, suggesting project-based or contract-based pricing.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
BioValeo Ltd product offering
Product offeringCore offering
BioValeo Ltd is a Contract Research Organisation (CRO) providing bespoke clinical trial services across Australia and New Zealand, with a specialist focus on advanced therapy medicinal products (ATMP) and complex clinical trials. The company delivers study country planning, regulatory submissions, project management, data management, and monitoring services to pharmaceutical and biotech sponsors running clinical studies in the region.
Product overview
BioValeo Ltd operates as a bespoke Contract Research Organisation (CRO) providing clinical trial services across Australia and New Zealand. The company offers a unified service portfolio comprising five integrated service modules: Study Country Planning, Regulatory Submissions, Project Management, Data Management, and Monitoring Services. These services are designed to work together throughout the clinical trial lifecycle, from regulatory submissions and study planning through data management and monitoring to trial closeout. BioValeo specializes in advanced therapy medicinal products (ATMP) and complex clinical trials, delivering personalized solutions tailored to each study and client's unique needs.
Differentiator
Problem solved
Functional benefit
Products and services
- Study Country Planning
Companies that use BioValeo Ltd
Customer profileSegments2 records
Ideal customer profiles1 record
BioValeo Ltd technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
BioValeo Ltd partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Callaghan InnovationcoreBioValeo is part of Callaghan Innovation's Technology Incubator Programme. Callaghan Innovation is New Zealand's innovation agency that activates innovation and helps businesses grow faster. The programme provides access to 200+ leading scientists and engineers, connections to opportunities and networks, tailored technical solutions, skills and capability development programmes, and grants co-funding.
Scale indicators2 records
Recent moves4 records
Expansion highlights3 records
BioValeo Ltd competitors and assessment
Company assessmentMarket position
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
BioValeo Ltd social profiles
Digital presenceBioValeo Ltd financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioValeo Ltd leadership team
Management profileNumber of profiles
BioValeo Ltd funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioValeo Ltd M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioValeo Ltd
What does BioValeo Ltd do?
BioValeo Ltd is a Contract Research Organisation (CRO) providing bespoke clinical trial services across Australia and New Zealand, with a specialist focus on advanced therapy medicinal products (ATMP) and complex clinical trials. The company delivers study country planning, regulatory submissions, project management, data management, and monitoring services to pharmaceutical and biotech sponsors running clinical studies in the region.
Is BioValeo Ltd a public or private company?
BioValeo Ltd is a private company. It is classified as venture growth investor backed and is currently operating.
When was BioValeo Ltd founded?
BioValeo Ltd was founded in -1. It employs 1 to 10 people.
Where is BioValeo Ltd based?
BioValeo Ltd is headquartered in Wellington, New Zealand, in the Oceania region.
How does BioValeo Ltd make money?
One revenue line is on record: CRO Professional Services.
Does BioValeo Ltd have an API?
No public API is recorded for BioValeo Ltd.
What industry is BioValeo Ltd in?
BioValeo Ltd's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 5417 and its SIC code is 8731.